Product pipeline
Lead candidate Mangoral (phase III ready) is an MRI imaging drug being developed for detection and localization of liver metastases.
Oncoral (in phase I) is a novel tablet-based irinotecan formulation, intended for treatment of advanced gastric (stomach) cancer.
